Tumor‐specific variants were most frequently detected in TP53 (20.0% of all variants), MAP3K1 (10.0%), AKT1 (8.6%), PIK3CA (7.1%), and GATA3 (7.1%) (Figure 4A,B). This evidence concerns the gene TP53 and neoplasm.